During the past decade, Tampere University Hospital, Department of Plastic Surgery conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tampere University Hospital, Department of Plastic Surgery" are "Secondary Lymphedema" (2 trials). Many other conditions were trialed in "Tampere University Hospital, Department of Plastic Surgery" in a lesser frequency.

Most popular intervention types in "Tampere University Hospital, Department of Plastic Surgery" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lymfactin® (1x10E11 vp)" (1 trials), "Lymfactin® [1 x 10E10 vp]" (1 trials), "Lymfactin® [1 x 10E11 vp]" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tampere University Hospital, Department of Plastic Surgery" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tampere University Hospital, Department of Plastic Surgery". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tampere University Hospital, Department of Plastic Surgery, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tampere University Hospital, Department of Plastic Surgery, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".